 random double-blind studi gallium nitrat etidron acut control cancer-rel hypercalcemia hypercalcemia major sourc morbid mortal patient cancer gallium nitrat bisphosphon etidron new agent avail treatment disord therapeut effect double-blind multicent studi gallium nitrat etidron acut control cancer-rel hypercalcemia gallium nitrat continu intraven IV infus dose etidron IV infus dose mg/kg drug consecut day elig patient persist moderate-to-sever hypercalcemia total serum calcium serum albumin equal mg/dl day hospit IV hydrat patient patient gallium nitrat normocalcemia patient etidron etidron amount IV fluid hypocalcem drug treatment poststudi period patient gallium nitrat kaplan-mei analysi median durat normocalcemia patient gallium nitrat day day proport patient gallium nitrat asymptomat hypophosphatemia patient etidron gallium nitrat effect superior acut control moderate-to-sever cancer-rel hypercalcemia